Deadline:
6/08/2020 |
Providing Enhanced Medical Support for Patients with Primary Immunodeficiency (PI) Disorders |
Pfizer Inc. |
Discipline:
- Curriculum Development
- Medical
- Medical - Clinical Science
|
Who's Eligible:
|
Award Amount:
$250,000 |
4/18/2022 |
Deadline:
7/07/2020 |
Incorporating Biosimilar Treatment Options in Solid Tumor Education Programs |
Pfizer Inc. |
Discipline:
- Curriculum Development
- Medical
- Medical - Clinical Science
- Medical - Translational
|
Who's Eligible:
|
Award Amount:
See solicitation for details |
4/18/2022 |
Deadline:
7/09/2020 |
NSCLC – Current Practice Considerations |
Pfizer Inc. |
Discipline:
- Curriculum Development
- Medical
- Medical - Clinical Science
- Medical - Translational
|
Who's Eligible:
|
Award Amount:
$250,000 |
4/18/2022 |
Deadline:
7/13/2020 |
Increasing Awareness of Nuclear Scintigraphy in Cardiac Amyloidosis |
Pfizer Inc. |
Discipline:
- Curriculum Development
- Medical
- Medical - Clinical Science
|
Who's Eligible:
|
Award Amount:
$75,000 |
4/18/2022 |
Deadline:
7/14/2020 |
Atopic Dermatitis Patient Education |
Pfizer Inc. |
Discipline:
- Curriculum Development
- Medical
- Medical - Clinical Science
|
Who's Eligible:
|
Award Amount:
$200,000 |
4/18/2022 |
Deadline:
7/20/2020 |
Management of Non-Communicable Diseases (NCD) for Health Care Providers |
Pfizer Inc. |
Discipline:
- Curriculum Development
- Medical
- Medical - Clinical Science
|
Who's Eligible:
|
Award Amount:
$250,000 |
4/18/2022 |
Deadline:
7/22/2020 |
2020 Osteoarthritis and Osteoarthritis Pain- Virtual Learning Competitive Grant Program |
Pfizer Inc. |
Discipline:
- Curriculum Development
- Medical
- Medical - Clinical Science
|
Who's Eligible:
|
Award Amount:
$250,000 |
4/18/2022 |
Deadline:
7/30/2020 |
NASH – Future of Non-invasive Diagnosis Technologies |
Pfizer Inc. |
Discipline:
- Curriculum Development
- Medical
- Medical - Clinical Science
|
Who's Eligible:
|
Award Amount:
$250,000 |
4/18/2022 |
Deadline:
7/30/2020 |
Telehealth Solutions in Atopic Dermatitis for Improving Education and Patient Care |
Pfizer Inc. |
Discipline:
- Curriculum Development
- International Opportunities
- Medical
- Medical - Clinical Science
|
Who's Eligible:
|
Award Amount:
$50,000 |
4/18/2022 |
Deadline:
8/07/2020 |
Use of Biosimilar Agents in Inflammatory Conditions |
Pfizer Inc. |
Discipline:
- Curriculum Development
- Medical
- Medical - Clinical Science
|
Who's Eligible:
|
Award Amount:
$200,000 |
4/18/2022 |
Deadline:
8/27/2020 |
Continuity of Care: Education for Rheumatology Patients Competitive Grant Program |
Pfizer Inc. |
Discipline:
- Curriculum Development
- Medical
- Medical - Clinical Science
- Medical - Translational
|
Who's Eligible:
|
Award Amount:
$150,000 |
4/18/2022 |
Deadline:
9/03/2020 |
Telehealth in Postmenopausal Patient Care |
Pfizer Inc. |
Discipline:
- Curriculum Development
- Medical
- Medical - Clinical Science
|
Who's Eligible:
|
Award Amount:
$100,000 |
4/18/2022 |
Deadline:
9/30/2020 |
Addressing Knowledge Gaps in Growth Hormone Deficiency |
Pfizer Inc. |
Discipline:
- Curriculum Development
- Medical
- Medical - Basic Science
- Medical - Clinical Science
- Medical - Translational
|
Who's Eligible:
|
Award Amount:
See solicitation for details |
4/18/2022 |
Deadline:
11/02/2020 |
Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision Making |
Pfizer Inc. |
Discipline:
- Curriculum Development
- Medical
- Medical - Clinical Science
|
Who's Eligible:
|
Award Amount:
$100,000 |
4/18/2022 |
Deadline:
11/02/2020 |
Biosimilars in Hematologic Malignancies & Supportive Care |
Pfizer Inc. |
Discipline:
- Curriculum Development
- International Opportunities
- Medical
- Medical - Clinical Science
|
Who's Eligible:
|
Award Amount:
See solicitation for details |
4/18/2022 |
Deadline:
11/02/2020 |
Data+ 2021: Request for Proposals (Faculty-sponsored Projects) |
Duke University |
Discipline:
- Community Outreach and Engagement
- Curriculum Development
- Engineering and Physical Sciences
- Environmental & Life Sciences
- Interdisciplinary
- Social Sciences
|
Who's Eligible:
|
Award Amount:
See solicitation for details |
4/18/2022 |